🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Get Started
Robert Weisskoff

Robert Weisskoff

Senior Partner·F-Prime

Cambridge, MA, USA
LinkedIn Bio source

Bio

Professional summary

Robert Weisskoff is a Senior Partner at F-Prime, where he joined in 2004 after senior R&D and business development roles in pharmaceutical and medical device companies. He previously held academic roles at Harvard Medical School, the Harvard-MIT Health Sciences Technology Program, and Massachusetts General Hospital’s MGH-NMR Center. He serves on boards including Adela, Affinia Therapeutics, Countable Labs, Plasmagen Biosciences, RareCyte, Shinobi Therapeutics, and Zenflow.

Notable companies

Selected portfolio companies the partner has backed

AdelaAffinia TherapeuticsRareCyteShinobi TherapeuticsZenflow

Background

Career, education, and skills

Career history

  • F-Prime CapitalSenior Partner2004 – Present
  • Pharmaceutical and Medical Device CompaniesSenior R&D and Business Development Roles
  • Harvard Medical SchoolAssociate Professor of Radiology
  • Harvard-MIT Health Sciences Technology ProgramFaculty Member
  • Massachusetts General HospitalAssociate Director, MGH-NMR Center

Education

  • Columbia UniversityMBA
  • Massachusetts Institute of TechnologyPhD in Physics
  • Harvard UniversityAB in Physics

Other partners at F-Prime

12 more profiles

View firm →
Abdul Abdirahman

Abdul Abdirahman

Principal

F-Prime

Principal investing in early-stage B2B software, fintech, and vertical SaaS.

B2B softwareEarly-stage investingEmerging marketsFintechVertical SaaS
Alex Pasteur

Alex Pasteur

Partner

F-Prime

Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.

Life SciencesTherapeutics
AP

Anastasiya Sybirna, PhD

Senior Associate

F-Prime

Senior Associate on F-Prime's London healthcare investment team.

BiopharmaHealthcareLife sciencesPharmaceuticalsTherapeutics
Bala Varadhan

Bala Varadhan

Principal

F-Prime

Principal focused on early-stage crypto, blockchain and Web3 investments.

BlockchainCryptoDigital assetsEarly-stage investingWeb3
Benjamin Gorman

Benjamin Gorman

Principal

F-Prime

Principal investing in early-stage enterprise software and AI.

AIDataEarly-stage investingEnterprise softwareMachine learning
Betsy Mulé

Betsy Mulé

Principal

F-Prime

Principal investing in enterprise technology and robotics.

B2B softwareEarly-stage investingEnterprise technologyFrontier technologyRobotics
Brett Cook

Brett Cook

Partner

F-Prime

F-Prime Partner investing in healthcare technology and services companies.

care deliverydigital healthhealthcare datahealthcare serviceshealthcare technology
Brian Yordy

Brian Yordy

Principal

F-Prime

Principal investing in biopharmaceutical and medical technology companies.

BiopharmaceuticalsHealthcareLife sciencesMedical technologyTherapeutics
Carl Bradford Byers 🚑

Carl Bradford Byers 🚑

Partner

F-Prime

F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.

digital healthfintechhealthcare IThealthcare serviceshealthtech
Carl Byers

Carl Byers

Partner

F-Prime

Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.

HealthtechServices
Chance Mathisen

Chance Mathisen

Associate

F-Prime

Associate focused on early-stage enterprise software investments.

AIEarly-stage investingEnterprise softwareGo-to-market strategySoftware platforms
Chong Xu

Chong Xu

Partner

F-Prime

F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.

BiopharmaceuticalsChina healthcareCompany formationHealthcare investingMedical technology